BNET Industries

Market Cap:$148.5B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Susan Kim: Menopause: Marketing Fear
-
Takeda, Pfizer To Co-Promote Actos Type 2 Diabetes Drug In China - Update
-
Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes
-
REG-Pfizer Inc Pfizer Declares an 18-Cent First-Quarter 2010 Dividend
-
BRIEF: SEC probing insider-trading allegations
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Private security firms no longer able to provide police information checks
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Market Report -- In Play PFE
-
Protalix Completes NDA Submission for taliglucerase alfa for the Treatment of Gaucher's Disease
-
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
-
Conservationists salute two corporations
-
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV
-
2009: The Year That Was For Pfizer
News & Analysis
Filter by
drug company and pfizer inc. - All News and Analysis
Ranking of 20 Drug Companies' Sales Forces Shows Productivity Flat or Declining
A ranking of drug company sales productivity shows Gilead gets the most revenues in return for every dollar invested in reps and marketing. At the other end of the table, Sepracor gets the least bang for its sales, general and administrative buck see table below. ...
NEJM: Foreign Drug Trials Could Hurt U.S. Patients
The increasing use of foreign drug trials may hurt U.S. patients because of genetic and environmental differences in overseas study subjects, a new study in the New England Journal of Medicine suggests. "Are trial results accurate and valid, and can they be extrapolated to other settings?" asks a team from...
FDA Caves to Pfizer, Industry on Antibiotics Ruling
The Food and Drug Administration has quietly withdrawn its order banning extralabel use of the antibiotic cephalosporin, so that it can "fully consider the comments" it has received on the issue. When the agency announced the order on July 3, drug companies and agriculture groups were outraged....
Pfizer Leads in Layoffs While Drug Prices Soar
Big Pharma continues to lend new meaning to the phrase "doing more with less," because while the industry seems to get smaller every day, drugmakers are still pushing through big price increases on their leading products. Over at Pharmalot, Ed Silverman provides a helpful roundup tracking the...
PFIZER TO CUT DOWN 2,200 JOB
AsiaInfo Services 12-04-2006 Pfizer to Cut down 2,200 Job SHANGHAI, Dec 04, 2006 SinoCast via COMTEX -- Pfizer Inc., the world's largest drugmaker, said on November 29 that it will axe 2,200 employees in its sales department in US, accounting ...
No magic potion; State life-science companies look for ways to survive, not a magic formula for success.
Becoming the next Pfizer Inc., Merck & Co. or Bristol-Myers Squibb Co. isn't the first concern of the state's growing number of life-science companies. They're more concerned with looking for ways to sustain their businesses while facing a lim Becoming the next Pfizer...
Pfizer's prospects look good without Lambert;Analysts expected rebound in shares, but now merger adds uncertainty .(Brief Article)
A combination of drugmakers, Pfizer Inc. and Warner-Lambert Co., would create the largest drug company in the world. But even if Pfizer isn't successful in luring Warner-Lambert into its fold, analysts say, the Manhattan-based drug company will be we A combination of drugmakers, Pfizer Inc. and...
Manufacturing Phil: A Drug's Life
A Pfizer public education campaign and its cute mascot are praiseworthy, but neglect to mention the key stage in a drug's life. What will it take to make manufacturing a hot button issue and to better educate the public? Given the current consumer and media backlash against drug makers, there's...
- 1
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes

